Pharma Marketing News
Pharma Marketing News Subscribe Glossary Daily Pharma News Feeds
Pharma Marketing Blog Discussion Forums Audio Podcasts Conference Calendar Reader Surveys

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
Share |

FDA Draft Guidance for Print DTCA
Less than Feared

On February 4, 2004, the FDA issued long-awaited draft guidance documents designed to improve communications to consumers and health care practitioners about health conditions and medical products. The most eagerly anticipated guidance concerns the acceptable alternatives to the lengthy, detailed, and technically-written "brief summary" of risk information for consumer-directed print advertisements for prescription drugs.

This article reviews the new guidance and includes comments from Jack E. Angel, Executive Director of the Coalition for Healthcare Communication and Harry Sweeney, CEO of Dorland Global Health Communications.

Read this article now. It's FREE...

Download PDF file

PMN32-03
Issue: Vol. 3, No. 2: February 2004
Word Count: 1319

Find other articles in related Topic Areas:

Vol 3, #2 Contents









Search All Pharma Marketing News Pages

Pharma Marketing News Email Addr:  

Contact Information
Editor
Pharma Marketing News


Pharma Marketing News | Subscribe | Discussion Forums | Podcasts | Blog
Daily News Briefs | Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2013. VirSci Corporation. All rights reserved.